---
title: Test biophoton therapy for tremor
nct_id: NCT06147999
phase: NA
status: RECRUITING
sponsor: First Institute of All Medicines
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06147999"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06147999"
last_fetched: "2026-05-10T14:03:50.416Z"
source: "Parkinson's Pathways (curated)"
---
# Test biophoton therapy for tremor

**Goal (in five words):** Test biophoton therapy for tremor

**Official Title:** Impact of a Biophoton Therapy on Patients With Brain Disorders

**Trial ID:** [NCT06147999](https://clinicaltrials.gov/study/NCT06147999)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** First Institute of All Medicines
- **Target Enrollment:** 80 participants
- **Start Date:** 2023-11-08
- **Completion Date:** 2026-11-08
- **Conditions:** Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury
- **Interventions:** Biophotonizer - a Biophoton Generator
- **Intervention Types:** DEVICE

## Summary For Families

Researchers want to see whether a handheld Biophotonizer light treatment can change brain function or symptoms in people with brain disorders, including Parkinson's, by promoting cellular signaling and lowering harmful inflammation. The approach uses a non-drug device that emits very low intensity biophoton light aimed at stimulating neurons and repair pathways, and it is given during an in-person hotel stay while participants keep their usual medications rather than replacing levodopa. Adults 18 and older with a clinical diagnosis of a brain disorder who can stay in a hotel and bring a caregiver to help with visits and surveys can join. People with implanted electronic devices like DBS or pacemakers, those on ventilators, with unstable medical conditions, active infections, pregnancy, or enrolled in another investigational trial are excluded.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Must meet conditions for approval.
* Must be 18-years or older and stay in a hotel.
* Must have a caregiver willing to support the participant's full involvement in the study. • The caregiver can assist in completing all study surveys.
* Can provide informed consent or can be assisted by caregiver.
* Can provide a clinical diagnosis of a brain disorder.
* Can complete all study procedures during the study.
* Must be fluent in English (or the Caregiver can fully translate).
* Women of childbearing age must provide results of a pregnancy test in order to participate.

Exclusion Criteria:

* Any untreated mental illnesses, that would affect study participation. This will be judged by the caregiver, or by the clinical study medical expert.
* Someone that relies on a ventilator.
* Someone who has a deep brain stimulator, pacemaker, or any implanted electronic devices.
* Co-morbid conditions that would interfere with study activities or response to treatment, which may include severe chronic pulmonary disease, history of uncontrolled seizures, acute or chronic infectious illness, severe diabetes, kidney failure, or any end-of-life prognosis.
* Is participating in another investigational drug or device trial.
* Has an active infectious disease, such as COVID-19.
* Pregnant women.
```

## Locations (1)

- Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001, Butler, Pennsylvania, United States _(40.8612, -79.8953)_
  - Jessica Jackson, PhD Candidate — (CONTACT) — 3029222486 — jessica.jackson@firstallmed.org
  - Audrey Ager — (CONTACT) — 7248101020 — Audrey.ager@teslabiohealing.com
  - Mariola Smotrys, MD, MS, MBA — (PRINCIPAL_INVESTIGATOR)
  - Larry Alpert, MD — (SUB_INVESTIGATOR)

---

*Canonical: https://parkinsonspathways.com/trial/NCT06147999*  
*HTML version: https://parkinsonspathways.com/trial/NCT06147999*  
*Source data: https://clinicaltrials.gov/study/NCT06147999*